Peter Gee

Kawahara, 6068507, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein.

Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein.

Journal: Stem cell reports
Published: August 14, 2020

CRISPR-Cas3 induces broad and unidirectional genome editing in human cells.

CRISPR-Cas3 induces broad and unidirectional genome editing in human cells.

Journal: Nature communications
Published: September 19, 2019

Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping.

Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping.

Journal: Nature communications
Published: March 13, 2019

Efficient mRNA delivery system utilizing chimeric VSVG-L7Ae virus-like particles.

Efficient mRNA delivery system utilizing chimeric VSVG-L7Ae virus-like particles.

Journal: Biochemical and biophysical research communications
Published: September 06, 2018

Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility.

Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility.

Journal: Cell stem cell
Published: July 01, 2018

Site-specific randomization of the endogenous genome by a regulatable CRISPR-Cas9 piggyBac system in human cells.

Site-specific randomization of the endogenous genome by a regulatable CRISPR-Cas9 piggyBac system in human cells.

Journal: Scientific reports
Published: October 03, 2017

Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy.

Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy.

Journal: Stem cells international
Published: January 24, 2017

Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases.

Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases.

Journal: International journal of molecular sciences
Published: August 26, 2015

Efficient genomic correction methods in human iPS cells using CRISPR-Cas9 system.

Efficient genomic correction methods in human iPS cells using CRISPR-Cas9 system.

Journal: Methods (San Diego, Calif.)
Published: July 16, 2015

Perspectives of Genome-Editing Technologies for HIV Therapy.

Perspectives of Genome-Editing Technologies for HIV Therapy.

Journal: Current HIV research
Published: March 10, 2014

Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells.

Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells.

Journal: Cell host & microbe
Published: June 28, 2012

Vpu and BST2: Still Not There Yet?

Vpu and BST2: Still Not There Yet?

Journal: Frontiers in microbiology
Published: January 23, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026